ArticleAnnals of clinical and translational neurology2026
Temporal Interference Stimulation of Centromedian-Parafascicular Complex in Disorders of Consciousness: A Pilot Study.
Article in Annals of clinical and translational neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveTreatment of disorders of consciousness (DoC) remains a major clinical challenge, and noninvasive, targeted modulation of deep brain structures has emerged as a promising therapeutic strategy. We aimed to evaluate the feasibility/safety and preliminary effects of thalamic temporal interference stimulation (TIS) targeting centromedian-parafascicular (CM-PF) complex in patients with DoC.
methodsWe conducted a single-arm, self-controlled trial in nine patients with DoC. All patients received TIS targeting the bilateral CM-PF complex once daily for 10 consecutive days. Stimulation targets were guided by patient-specific electric field modeling to ensure precise neuromodulation. Outcome measures included adverse events, the change in Coma Recovery Scale-Revised (CRS-R) total and subscale scores from baseline to after five and 10 stimulation sessions, and alterations in EEG "ABCD" patterns and power spectral density (PSD) following the tenth session.
resultsNo serious adverse events were reported. After 10 stimulation sessions, CRS-R total scores increased significantly, with improvements primarily observed in the auditory, visual, and motor subscales. No significant changes in CRS-R scores were detected after five stimulation sessions. EEG analyses demonstrated an increased prevalence of patterns C and D, disappearance of pattern A, and elevated global PSD in the alpha and beta frequency bands after 10 stimulation sessions.
interpretationThis pilot study demonstrates that thalamic TIS is a safe and feasible noninvasive deep brain stimulation technology that may facilitate consciousness recovery in patients with DoC. Larger randomized controlled trials with longer follow-up are needed to confirm these preliminary observations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.